Exane Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Exane Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200,000	Closed	-$800K	–	28
2019 Q4	$800K	Buy	+200,000	New	+$939K	0.98%	23

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Exane Asset Management's DPLO Position: Q1 2020 in Review

Exane Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 200,000 shares — an estimated $800K sold.

Exane Asset Management first reported a position in DPLO in Q4 2019 and held it in 1 quarter. The position peaked at $800K in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Exane Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Exane Asset Management sold 200,000 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $800K.
Exane Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2019 and held it in 1 quarter.
Exane Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $800K in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Exane Asset Management's 13F filing for Q1 2020, filed 22 Apr 2020.